Most Recent

image: TS Picks: June 6, 2016

TS Picks: June 6, 2016

By | June 6, 2016

American Society of Clinical Oncology meeting edition 

0 Comments

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Generating Cardiac Precursor Cells

Generating Cardiac Precursor Cells

By | June 1, 2016

Researchers derive cardiac precursors to form cardiac muscle, endothelial, and smooth muscle cells in mice.

0 Comments

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: The Fatty Acid–Ketone Switch

The Fatty Acid–Ketone Switch

By | June 1, 2016

In failing hearts, cardiomyocytes change their fuel preference.

1 Comment

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: In Failing Hearts, Cardiomyocytes Alter Metabolism

In Failing Hearts, Cardiomyocytes Alter Metabolism

By | June 1, 2016

While the heart cells normally burn fatty acids, when things go wrong ketones become the preferred fuel source.

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

2 Comments

Exposing male rats to nonionizing radiation increased the animals’ risk of brain and heart tumors in a study, but the findings are far from conclusive.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech